What does life feel like for children with a rare birth defect? a new study asks
NCT ID NCT06439862
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study aims to understand the quality of life of school-aged children who were treated for posterior urethral valves (PUV) in their first year of life. PUV is a rare birth defect that can affect kidney and bladder function. Researchers will use a standard questionnaire called PedsQL 4.0 to measure how these children feel about their physical, emotional, social, and school life, and will also ask parents for their perspective. The goal is to gather information that can help improve care and support for children with this condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide a clearer picture of how posterior urethral valves affect children's daily lives, helping families and doctors make more informed decisions about care and support.
- What could go wrong
- This is an observational study, so it won't test a new treatment. The results may not apply to all children with this condition, and quality of life is subjective, varying from child to child.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2024
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children with PUV will be selected inside the database of the pediatric surgery department of the Femme-Mère-Enfant Hospital in Lyon
- Ages
-
6 to 17 years
- Sex
-
Male participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male patients and their parents/relatives * Aged 6 to 17 years old * Treated for PUV in their first year of life between 2006 and 2018 * Managed in the Femme-Mère-Enfant Hospital in Lyon Exclusion Criteria: * Children with pre-existing severe cognitive and physical disability (physician's rating) from other condition * Children enable to complete QoL questionnaire due to mental or communication impairment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bladder dysfunction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Femme-Mère-Enfant Hospital
RECRUITINGBron, Bron, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a deep breath and a hint of lemongrass take the sting out of dialysis needles?
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Can better training get doctors to talk about what matters most to dying veterans?